Cited by 89Reproductive tract infections researchHIV/AIDS Research and InterventionsUrinary Tract Infections Management

Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial.

Kissinger, Patricia, Schmidt, Norine, Mohammed, Hamish, Leichliter, Jami S., Gift, Thomas L., Meadors, Bernadette, Sanders, Cheryl, Farley, Thomas A.·2006·Sexually Transmitted Diseases

Abstract

In Brief Objectives: Infections with Trichomonas vaginalis (TV) are common and recurrence rates are high. Better methods of treating partners of women with trichomoniasis are needed. Goal: To determine if patient-delivered partner treatment (PDPT) is better and more cost-effective than partner referral. Study Design: Women attending a family planning clinic who were culture-positive and treated for TV (N = 463) were randomized to either standard partner referral (PR), booklet-enhanced partner referral (BEPR), or PDPT. At baseline and 1 month, women were interviewed and cultured for TV. Detailed cost information was also collected. Results: Most women had 1 partner, were less than 24 years old, and were black. The percentage of women reporting that their partners were treated was similar for PDPT but significantly lower for BEPR compared to PR. TV follow-up rates were similar. PDPT cost less and was cost saving compared to PR and BEPR. Conclusion: Among women with TV, PDPT did not result in more partners taking the medicine or lower follow-up rates than PR but was less costly. An RCT of partner treatment for women with Trichomonas vaginalis showed that patient-delivered partner treatment was similar to partner referral for partners treated and recurrence rates but was more cost-effective.

Integrity signals

Registry

Crossref · 10.1097/01.olq.0000204511.84485.4c

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Existing data indicate that EPT might have a role in partner management for trichomoniasis; however, no partner management intervention has been reported to be more effective than any other in reducing trichomoniasis reinfection rates.

    “Existing data indicate that EPT also might have a role in partner management for trichomoniasis; however, no partner management intervention has been reported to be more effective than any other in reducing trichomoniasis reinfection rates (129,130).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [129]

  • Eleven studies compared expedited partner therapy versus simple patient referral among patients with chlamydial infection, trichomoniasis, gonorrhoea or chlamydia, HIV, herpes simplex virus-2, syphilis, or any STI syndrome.

    “Eleven studies compared EPT versus simple patient referral among patients with chlamydial infection (99, 113), trichomoniasis (89, 90), gonorrhoea or chlamydia (94, 95, 114-116), HIV, herpes simplex virus-2, syphilis, chlamydial infection, gonorrhoea (pharyngeal and anal) (117), or any STI syndrome (108).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kissinger, P., Schmidt, N., Mohammed, H., Leichliter, J. S., Gift, T. L., Meadors, B., Sanders, C., & Farley, T. A.
Affiliations
  • Tulane University (US)
  • Centers for Disease Control and Prevention (US)
  • Louisiana State University (US)
Corresponding author
  • Kissinger, Patricia
  • Schmidt, Norine
  • Mohammed, Hamish
  • Sanders, Cheryl
  • Farley, Thomas A.
Venue
Sexually Transmitted Diseases
Published
2006-07
Volume
33
Issue
7
Pages
445-450
ISSN
0148-5717 (ISSN-L)
OpenAlex
W1999105470
Cited by
89
References
31
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 8 · 2014: 2 · 2013: 6 · 2012: 2
FWCI
4.16
Type
journal article
Language
en
Open access
closed
Locations
  • Sexually Transmitted Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Public Health Service (R30/CCR619146)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Epidemiology › Urinary Tract Infections Management
Keywords
Trichomonas vaginalis, trichomoniasis, cost-effectiveness, recurrence, sexually transmitted infections, women's health
MeSH terms
Adult, Animals, Antiprotozoal Agents, Cost-Benefit Analysis, Female, Humans, Louisiana, Male, Metronidazole, Preventive Health Services, Referral and Consultation, Sexual Partners, Trichomonas vaginalis, Trichomonas Vaginitis, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review